Drug Free Solution, Inc.
DSOL
$0.0002
$0.000.00%
| 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | 02/28/2013 | |
|---|---|---|---|---|---|
| Revenue | -- | 2.10K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 2.10K | -- | -- | -- |
| Cost of Revenue | -- | 2.90K | 38.50K | 171.20K | -- |
| Gross Profit | -- | -800.00 | -38.50K | -171.20K | -- |
| SG&A Expenses | 120.30K | 96.10K | 12.00K | 400.70K | 114.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 120.30K | 127.00K | 50.50K | 572.00K | 114.70K |
| Operating Income | -120.30K | -124.90K | -50.50K | -572.00K | -114.70K |
| Income Before Tax | -120.30K | -124.90K | -50.50K | -572.00K | -114.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -120.30K | -124.90K | -50.50K | -572.00K | -114.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -120.30K | -124.90K | -50.50K | -572.00K | -114.70K |
| EBIT | -120.30K | -124.90K | -50.50K | -572.00K | -114.70K |
| EBITDA | -116.80K | -123.40K | -50.20K | -571.70K | -113.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 104.92M | 102.05M | 85.93M | 83.35M | 85.16M |
| Average Diluted Shares Outstanding | 104.92M | 102.05M | 85.93M | 83.35M | 85.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
